Results 271 to 280 of about 988,166 (377)
Stndies on the Treatment of Malignant Tumors with Fibroblast-Inhibiting Agent
Hidenari Kodani
openalex +2 more sources
Beta‐glucans have gained significant attention as an immunomodulatory biomaterial with cell‐targeting capabilities. This review comprehensively outlines the design and fabrication methods for producing beta‐glucan particles at both the micro and nanoscale and their applications in immune cell targeting, immunomodulation, and drug delivery ...
Nate Dowdall, Todd Hoare
wiley +1 more source
Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk. [PDF]
Quatrana A+5 more
europepmc +1 more source
Designing for Degradation: Transient Devices Enabled by (Nano)Cellulose
Recent progress in transient devices enabled by (nano)cellulosic materials is reviewed. Transiency mechanisms, advantages of nanocelluloses, and a suite of applications are discussed. A circular thinking approach coupled with life cycle assessment is applied to critically revisit the potential, advantages, and challenges of nanocellulose‐enabled ...
Lucas J. Andrew+2 more
wiley +1 more source
PGC-1α mediates migrasome secretion accelerating macrophage-myofibroblast transition and contributing to sepsis-associated pulmonary fibrosis. [PDF]
Peng Y+12 more
europepmc +1 more source
Stem cell spheroids, produced via a high‐throughput microfabrication technique, are transported within a vortex generated at the outlet channels of a cross‐slot millifluidic chip. For Reynolds number exceeding 170–200, intermittent high shear stresses applied to each spheroid within the vortex trigger a massive release of biologically active ...
Elliot Thouvenot+8 more
wiley +1 more source
RNA-sequencing demonstrates transcriptional differences between human vocal fold fibroblasts and myofibroblasts. [PDF]
Bretl M+3 more
europepmc +1 more source
Protein can undergo liquid–liquid phase separation and liquid‐to‐solid transition to form liquid condensates and solid aggregates. These phase transitions can be influenced by post‐translational modifications, mutations, and various environmental factors.
Tianchen Li+3 more
wiley +1 more source
Leveraging cardiac reprogramming with CRISPRa-SAM technology. [PDF]
Borthakur A, Venugopal KN, Thummer RP.
europepmc +1 more source